Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause.

Tekturk P. et al, (2018), Brain Dev, 40, 909 - 917

Plasma cell depletion with bortezomib in the treatment of refractory N-methyl-d-aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment.

Keddie S. et al, (2018), Eur J Neurol, 25, 1384 - 1388

Antiglycine receptor antibody related disease: a case series and literature review.

Swayne A. et al, (2018), Eur J Neurol, 25, 1290 - 1298

NMDA-receptor antibodies alter cortical microcircuit dynamics.

Rosch RE. et al, (2018), Proceedings of the National Academy of Sciences of the United States of America, 115, E9916 - E9925

Passive Transfer of Human CASPR2 Antibodies into Mice Causes Behavioral and Neuropathological Changes

Giannoccaro MP. et al, (2018), ANNALS OF NEUROLOGY, 84, S137 - S137

Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.

Vincent A. et al, (2018), JAMA neurology

SHP2 INHIBITION BY NSC-87877 RECOVERS THE PATHOGENIC IN VITRO EFFECTS OF MUSK-MG ANTIBODY SUBCLASSES

Cao M. et al, (2018), MUSCLE & NERVE, 58, S15 - S16

Glutamate receptor delta2 serum antibodies in paediatric opsoclonus myoclonus ataxia syndrome

Lang B. et al, (2018), Neurology

A passive transfer animal model of CASPR2 antibodies

Giannoccaro MP. et al, (2018), EUROPEAN JOURNAL OF NEUROLOGY, 25, 674 - 674

Brain-relevant antibodies in first-episode psychosis: a matched case-control study.

Gaughran F. et al, (2018), Psychol Med, 48, 1257 - 1263

Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.

Cetin H. and Vincent A., (2018), Semin Neurol, 38, 344 - 354

Clinical presentation and prognosis in MOG-antibody disease: a UK study (vol 140, pg 12, 2017)

Jurynczyk M. et al, (2018), BRAIN, 141

Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody.

Hacohen Y. et al, (2018), Multiple sclerosis (Houndmills, Basingstoke, England), 24, 679 - 684

Serological and experimental studies in different forms of myasthenia gravis (vol 1413, pg 143, 2018)

Vincent A. et al, (2018), ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1417, 130 - 130

Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability

Dawes JM. et al, (2018), Neuron

A prospective whole Scottish population study of genetic and immune causes of epilepsy and complex febrile seizures in children under three years of age: the Genetic and Autoimmune Childhood Epilepsy (GACE) Study

Symonds J. et al, (2018), SCOTTISH MEDICAL JOURNAL, 63, 35 - 36

High sensitivity and specificity in proposed clinical diagnostic criteria for anti-N-methyl-D-aspartate receptor encephalitis.

Ho ACC. et al, (2017), Dev Med Child Neurol, 59, 1256 - 1260

Cell- and Single Molecule-Based Methods to Detect Anti-N-Methyl-D-Aspartate Receptor Autoantibodies in Patients With First-Episode Psychosis From the OPTiMiSE Project.

Jézéquel J. et al, (2017), Biol Psychiatry, 82, 766 - 772

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient.

Saxena A. et al, (2017), Sci Rep, 7

Disease course and disability outcomes in MOG-antibody disease in the UK

Jurynczyk M. et al, (2017), MULTIPLE SCLEROSIS JOURNAL, 23, 82 - 82

Load More

Include forthcoming?